AbbVie Inc.
ABBV
$245.74
$1.940.79%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.16% | 12.43% | 10.04% | 9.10% | 6.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.16% | 12.43% | 10.04% | 9.10% | 6.65% |
| Cost of Revenue | -1.27% | 5.40% | 7.94% | 5.94% | 3.43% |
| Gross Profit | 14.64% | 15.45% | 10.85% | 10.40% | 7.96% |
| SG&A Expenses | 11.62% | 8.53% | 3.61% | -15.19% | -3.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 100.00% | -- | -- |
| Total Operating Expenses | 5.73% | 9.64% | 7.42% | -1.40% | 1.82% |
| Operating Income | 17.54% | 18.82% | 15.48% | 35.30% | 15.79% |
| Income Before Tax | 175.29% | -37.45% | 217.58% | -65.74% | -27.59% |
| Income Tax Expenses | 7.99% | -8.06% | 137.98% | 1.15% | -20.70% |
| Earnings from Continuing Operations | 284.27% | -45.93% | 7,991.30% | -87.98% | -31.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | 33.33% | 0.00% | 33.33% | 0.00% |
| Net Income | 285.18% | -45.96% | 8,354.55% | -88.08% | -31.53% |
| EBIT | 17.54% | 18.82% | 15.48% | 35.30% | 15.79% |
| EBITDA | 10.82% | 10.84% | 9.20% | 23.24% | 9.93% |
| EPS Basic | 287.81% | -46.18% | 5,724.31% | -88.65% | -31.76% |
| Normalized Basic EPS | 17.18% | 22.21% | 17.63% | 37.25% | 12.98% |
| EPS Diluted | 290.38% | -46.06% | 5,543.85% | -88.65% | -32.40% |
| Normalized Diluted EPS | 17.25% | 22.08% | 17.63% | 37.25% | 12.97% |
| Average Basic Shares Outstanding | 0.06% | 0.06% | 0.28% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.17% | 0.28% | 0.00% | 0.00% |
| Dividend Per Share | 5.49% | 5.49% | 5.49% | 5.81% | 5.81% |
| Payout Ratio | -0.73% | 0.95% | 1.01% | 7.88% | 0.55% |